BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Clinical Outcome
8 results:

  • 1. The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.
    Zhang H; Tian L; Wang X; Shi X
    Front Endocrinol (Lausanne); 2024; 15():1349041. PubMed ID: 38476675
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [clinical outcome of Robot-Assisted Distal Pancreatectomy in Our Institutional Introduction].
    Matsukawa H; Satoh D; Ishida M; Yoshimoto M; Idani H; Shirakawa Y; Nakano K; Yoshimitsu M; Choda Y; Yano T; Sawada H; Katsura Y; Okura T; Fukuhara S; Shiozaki S
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1671-1672. PubMed ID: 36733171
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse.
    Hollis RL; Carmichael J; Meynert AM; Churchman M; Hallas-Potts A; Rye T; MacKean M; Nussey F; Semple CA; Herrington CS; Gourley C
    Am J Obstet Gynecol; 2019 Sep; 221(3):245.e1-245.e15. PubMed ID: 31055034
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Treatment Strategy for Borderline Resectable Pancreatic cancer With Radiographic Artery Involvement.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
    Pancreas; 2016 Nov; 45(10):1438-1446. PubMed ID: 27088490
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2.
    Cohen S; Bruchim I; Graiver D; Evron Z; Oron-Karni V; Pasmanik-Chor M; Eitan R; Bernheim J; Levavi H; Fishman A; Flescher E
    J Mol Med (Berl); 2013 Mar; 91(3):357-68. PubMed ID: 23052480
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascites.
    Ott MG; Marmé F; Moldenhauer G; Lindhofer H; Hennig M; Spannagl R; Essing MM; Linke R; Seimetz D
    Int J Cancer; 2012 May; 130(9):2195-203. PubMed ID: 21702044
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
    Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.
    Barbieri F; Cagnoli M; Ragni N; Foglia G; Bruzzo C; Pedullà F; Alama A
    Clin Cancer Res; 1999 Jul; 5(7):1837-42. PubMed ID: 10430089
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.